Novo-Nordisk A/S (NVO) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

NVO Novo-Nordisk A/S

Watchlist

87.370
-1.340-1.51%

Close Dec 24 13:00 ET

87.320
-0.050-0.06%

Pre 07:01 ET

389.33BMarket Cap29.57P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Jim Cramer Says Novo Nordisk A/S (NVO) Can't Exceed Eli Lilly
Yahoo FinanceDec 25 07:12 ET
Novo Nordisk Is 'Losing Its Pep' in GLP-1 Race: BMO Analyst
Yahoo FinanceDec 25 06:30 ET
Novo Nordisk (NVO) Stock Drops Despite Market Gains: Important Facts to Note
Yahoo FinanceDec 24 17:45 ET
Novo-Nordisk A/S Options Spot-On: On December 24th, 32,364 Contracts Were Traded, With 453.78K Open Interest
Moomoo NewsDec 24 16:30 ET
Weight-loss Drugs in 2025, Auto Industry Outlook: Market Domination
Yahoo FinanceDec 24 14:40 ET
Novo Nordisk Stock Plunges 18% in a Week: What Should Investors Do?
Zacks Dec 24 08:00 ET

Comments

pootpoot

Dec 23 08:48

$Novo-Nordisk A/S (NVO.US)$
it was fun..

Share Your Profit/Loss

Movers and Shakers

Dec 23 07:35

Columns Today's Pre-Market Movers and Top Ratings | NVO, TSLA, TRAW and More

Morning Movers
Gapping up
$Novo-Nordisk A/S (NVO.US)$ shares rose 5%, recovering from an 18% drop in the previous session after its weight loss drug, CagriSema, posted disappointing late-stage trial results on Friday.
$Tesla (TSLA.US)$ gained 3% premarket, recovering from last week's 3.5% drop, its worst performance since before the U.S. presidential election.
$Traws Pharma (TRAW.US)$ shares surged 109% after announcing progress on...

Money Thrill

Dec 23 07:20

What to understand about statistics ?

$Novo-Nordisk A/S (NVO.US)$ Statistics are always open to interpretation. Never a 100 percent correct evaluation. In doing so, Novo also point out a number of RESEARCH LIMITATIONS. Less than SIX out of TEN obese patients would have used the highest permitted dose. Nevertheless, Novo Nordisk will ask the regulators of the pharmaceutical industry to allow the drug for commercialization.
So, would you care if a weight loss supplement only achieved a 22.7% weight ...

Ho Lee Fuk

Dec 23 02:45

$Novo-Nordisk A/S (NVO.US)$ 150 by this year

102532025

Dec 23 02:30

$Novo-Nordisk A/S (NVO.US)$ why the drop

Heat List

Overall

No Data

Investment Theme

Weight Loss Drugs

Intraday-0.42%